Review: taking Abilify and Invega together


Summary

Drug interactions are reported among people who take Abilify and Invega together. This review analyzes the effectiveness and drug interactions between Abilify and Invega. It is created by eHealthMe based on reports of 304 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Abilify and Invega >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Abilify

Abilify has active ingredients of aripiprazole. It is often used in bipolar disorder. (latest outcomes from Abilify 34,939 users)

Invega

Invega has active ingredients of paliperidone. It is often used in schizophrenia. (latest outcomes from Invega 5,437 users)

On Aug, 19, 2016

304 people who take Abilify, Invega are studied.


Number of reports submitted per year:

Abilify and Invega drug interactions.

Drug effectiveness over time:

Abilify:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Invega:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Abilify:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 1 people)
Invega:
  • female: 100.0% - (2 of 2 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Abilify:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Invega:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 50.0% - (1 of 2 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • hyperprolactinaemia
  • constipation
  • schizophrenia
  • irritability
  • drug ineffective
  • hypersensitivity
  • anxiety
  • nausea
  • disorientation
  • hypertension
1 - 6 months:
  • schizophrenia
  • blood cholesterol increased
  • suicide attempt
  • weight increased
  • hyperprolactinaemia
  • pelvic fracture
  • pneumothorax
  • psychotic disorder
  • splenic injury
  • colonic pseudo-obstruction
6 - 12 months:
  • weight increased
  • blood cholesterol increased
  • hyperprolactinaemia
  • diabetes mellitus
  • erectile dysfunction
  • haemoglobin decreased
  • hypertriglyceridaemia
  • liver function test abnormal
  • irritability
  • malaise
1 - 2 years:
  • type 2 diabetes mellitus
  • obesity
  • weight increased
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood cholesterol increased
  • blood triglycerides increased
  • cardiac disorder
  • gamma-glutamyltransferase increased
  • hepatic steatosis
2 - 5 years:
  • drug ineffective
  • erection increased
  • excessive eye blinking
  • eye rolling
  • feeling abnormal
  • impaired driving ability
  • nausea
  • acne cystic
  • anxiety
  • constipation
5 - 10 years:
  • concussion
  • fall
  • humerus fracture
  • hypotension
  • patella fracture
  • pruritus
  • tardive dyskinesia
not specified:
  • weight increased
  • hyperprolactinaemia
  • depression
  • psychotic disorder
  • type 2 diabetes mellitus
  • agitation
  • delirium
  • suicidal ideation
  • drug ineffective
  • abnormal behaviour

Most common drug interactions by gender *:

female:
  • hyperprolactinaemia
  • schizophrenia
  • depression
  • constipation
  • delirium
  • hypertension
  • anxiety
  • drug ineffective
  • type 2 diabetes mellitus
  • weight increased
male:
  • weight increased
  • hyperprolactinaemia
  • psychotic disorder
  • suicidal ideation
  • diabetes mellitus
  • irritability
  • hypertriglyceridaemia
  • type 2 diabetes mellitus
  • malaise
  • abnormal behaviour

Most common drug interactions by age *:

10-19:
  • suicide attempt
  • agitation
  • anxiety
  • cognitive disorder
  • fatigue
  • hallucination, auditory
  • irritability
  • multiple drug overdose intentional
  • somnolence
  • suicidal ideation
20-29:
  • depression
  • hyperprolactinaemia
  • mental impairment
  • psychotic disorder
  • weight increased
  • psychotic behaviour
  • schizophrenia
  • pelvic fracture
  • pneumothorax
  • splenic injury
30-39:
  • delirium
  • weight increased
  • bulimia nervosa
  • hypertriglyceridaemia
  • liver disorder
  • fatigue
  • alanine aminotransferase increased
  • diabetes mellitus
  • suicide attempt
  • psychomotor retardation
40-49:
  • type 2 diabetes mellitus
  • hyperprolactinaemia
  • psychotic disorder
  • abnormal behaviour
  • asthenia
  • polydipsia
  • extrapyramidal disorder
  • musculoskeletal stiffness
  • cervicobrachial syndrome
  • constipation
50-59:
  • drug ineffective
  • diabetes mellitus
  • somnolence
  • amnesia
  • headache
  • vomiting
  • weight increased
  • glucose tolerance increased
  • psychiatric symptom
  • abdominal distension
60+:
  • hyperprolactinaemia
  • irritability
  • schizophrenia
  • malaise
  • hyponatraemia
  • inappropriate antidiuretic hormone secretion
  • skin reaction
  • concussion
  • fall
  • humerus fracture

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Abilify and Invega?

Can you answer these questions?

More questions for: Abilify, Invega

You may be interested in these reviews

More reviews for: Abilify, Invega

On eHealthMe, Abilify (aripiprazole) is often used to treat bipolar disorder. Invega (paliperidone) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.